Vaginal Royal Jelly for Vulvovaginal Candidiasis Treatment: A Randomized Clinical Trial
Background: Vulvovaginal Candidiasis (VVC) is a prevalent and complex health issue in women. With the rising resistance to synthetic antifungal medications, there is a growing emphasis on exploring natural remedies that minimize disruption to the normal vaginal flora. The goal of this study is to ev...
Saved in:
| Main Authors: | Maryam Ramazany Chaleshtori, Mahmoodreza Madadian, Azadeh Akbari Sane, Farahnaz Farzaneh, Vida Kazemi, Fatemeh Montazer, Susan Sarhadi, Maryam Taghavi Shirazi, Shahla Mirgaloybayat |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-04-01
|
| Series: | Advanced Biomedical Research |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/abr.abr_69_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Population level of main microbiota and yeast-like Candida fungi in women with vulvovaginal candidiasis
by: N. D. Yakovychuk, et al.
Published: (2017-06-01) -
Carbohydrate Derived Fulvic Acid for the Treatment of Vulvovaginal Candidiasis
by: Stewart Clark, et al.
Published: (2024-12-01) -
Estimation of Immunoglobulins and complements and Using Enzyme linked Immuno sorbant Assay in Identification of Vulvovaginal candidiasis
by: Baghdad Science Journal
Published: (2009-09-01) -
Efficacy and safety of vaginal suppositories containing combination of Natamycin and Lactulose in treatment of vulvovaginal candidiasis: international, randomized, controlled, superiority clinical trial (combination of Natamycin and Lactulose for treatment of vulvovaginal candidiasis)
by: Oksana N. Volkova, et al.
Published: (2025-02-01) -
Risk factors for recurrent vulvovaginal candidiasis
by: Janković Slobodan, et al.
Published: (2010-01-01)